Formulation, Development & Delivery In-Depth Focus 2018

Posted: 19 December 2018 | | No comments yet

In this supplement: Real-time PCR detection of Staphylococcus aureus in pharmaceutical products contaminated with mixed bacterial cultures, and an ICH Q3C(R5) elemental impurities update.

Formulation, Development and Delivery In-Depth Focus cover 2018

The contamination of pharmaceuticals by microorganisms represents a major threat to public health. Regulatory agencies around the world require the absence of certain types of microorganisms that can be considered hazardous to consumers or compromise drug stability and efficacy. Luis Jimenez and colleagues, from Bergen Community College, New Jersey, US, present the results of a real-time PCR analysis used to detect Staphylococcus aureus in pharmaceutical products contaminated with mixed bacterial cultures.

The introduction of ICH Q3D – Guideline for Elemental Impurities – was an additional safety‑based guidance for toxic impurities. Dave Elder, of David P Elder Consultancy, discusses the current status of implementation of ICH Q3D in various regions and the impact on the principal pharmacopoeias. He also looks at analytical preparation, testing and validation as well as specification implications.

This In-Depth Focus is restricted - login or subscribe free to access

Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • bi-monthly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here